Laurent DECORY
COVID-19 to reshape R&D investments toward infectious diseases
Infectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...
top of page
For Pharma, Biotech, MedTech.
Commercialization: Implemented
Search
Laurent DECORY
- Dec 13, 2020
- 1 min
Post Brexit, will UK MedTech take back control or align with key markets ?
While Brexit goal is officially to "take back control", UK MedTech may have to choose between aligning regulatory process with EU or US....
0 views0 comments
Laurent DECORY
- Dec 12, 2020
- 1 min
Germany bets on its Biotechs and mRNA COVID-19 vaccines
After granting €252M to CureVac, the German government has awarded €375M to BioNTech. BioNtech announcement: https://lnkd.in/dKinEe4...
2 views0 comments
Laurent DECORY
- Dec 12, 2020
- 1 min
GENFIT moves focus to promising NASH diagnostic
In a promising but risky NASH market, study shows GENFIT NIS4 easy test allows to identify patients who require treatment, without need...
0 views0 comments
Laurent DECORY
- Dec 12, 2020
- 1 min
Biosimilars finally taking off in the US
Usage of Biosimilars has increased significantly in Europe, while usage in the US has been lagging behind. Now, Biosimilars are finally...
0 views0 comments
Laurent DECORY
- Dec 12, 2020
- 1 min
UCB’s Bimekizumab to reshape psoriasis market
The $ 20+ billion Psoriasis treatment market has been dominated by AbbVie's Humira. But things might change soon. After beating J&J’s...
4 views0 comments
bottom of page